Triangle Pharmaceuticals Inc Watch

from SC 13G/A 1 page Ex-1.1 Otherdoc 2 0002.txt Joint Filing Agreement Exhibit 1.1 Joint Filing Agreement the Undersigned Hereby Agree That the Statement on This Schedule 13g/A, Dated December 5, 2002, (The "Schedule 13g/A"), With Respect to the Common Stock, Par Value $0.001 Per Share, of Triangle Pharmaceuticals Inc. Is Filed on Behalf of Each of US Pursuant to and in Accordance With the Provisions of Rule 13d-1(k) Under the Securities and Exchange Act of 1934, as Amended, and That This Agreement Shall Be Included as an Exhibit to This Schedule 13g/A. Each of the Undersigned Agrees to Be Responsible for the Timely Filing of the Schedule 13g/A, and for the Completeness and Accuracy of the Information Concerning Itself Contained Therein. This Agreement May Be Executed in Any Number of Counterparts, All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Have Executed This Agreement as of the 5th Day of December, 2002. Orbimed Advisors Inc. By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: President Orbimed Advisors LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: Managing Member

from SC 13G/A 1 page Ex-1.1 Otherdoc 2 0002.txt Joint Filing Agreement Exhibit 1.1 Joint Filing Agreement the Undersigned Hereby Agree That the Statement on This Schedule 13g/A, Dated December 5, 2002, (The "Schedule 13g/A"), With Respect to the Common Stock, Par Value $0.001 Per Share, of Triangle Pharmaceuticals Inc. Is Filed on Behalf of Each of US Pursuant to and in Accordance With the Provisions of Rule 13d-1(k) Under the Securities and Exchange Act of 1934, as Amended, and That This Agreement Shall Be Included as an Exhibit to This Schedule 13g/A. Each of the Undersigned Agrees to Be Responsible for the Timely Filing of the Schedule 13g/A, and for the Completeness and Accuracy of the Information Concerning Itself Contained Therein. This Agreement May Be Executed in Any Number of Counterparts, All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Have Executed This Agreement as of the 5th Day of December, 2002. Orbimed Advisors Inc. By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: President Orbimed Advisors LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: Managing Member

from SC 13G/A 1 page Ex-1.1 Otherdoc 2 0002.txt Joint Filing Agreement Exhibit 1.1 Joint Filing Agreement the Undersigned Hereby Agree That the Statement on This Schedule 13g/A, Dated December 5, 2002, (The "Schedule 13g/A"), With Respect to the Common Stock, Par Value $0.001 Per Share, of Triangle Pharmaceuticals Inc. Is Filed on Behalf of Each of US Pursuant to and in Accordance With the Provisions of Rule 13d-1(k) Under the Securities and Exchange Act of 1934, as Amended, and That This Agreement Shall Be Included as an Exhibit to This Schedule 13g/A. Each of the Undersigned Agrees to Be Responsible for the Timely Filing of the Schedule 13g/A, and for the Completeness and Accuracy of the Information Concerning Itself Contained Therein. This Agreement May Be Executed in Any Number of Counterparts, All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Have Executed This Agreement as of the 5th Day of December, 2002. Orbimed Advisors Inc. By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: President Orbimed Advisors LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: Managing Member

from 8-A12G/A ~5 pages Underwriting agreement

from 8-A12G/A ~5 pages Underwriting agreement

from SC 13G 1 page Joint Filing Agreement Exhibit 1.1 Joint Filing Agreement the Undersigned Hereby Agree That the Statement on This Schedule 13g, Dated November 1, 2001, (The "Schedule 13g"), With Respect to the Common Stock, Par Value Nis 0.05 Per Share, of Triangle Pharmaceuticals Inc. Is Filed on Behalf of Each of US Pursuant to and in Accordance With the Provisions of Rule 13d-1(k) Under the Securities and Exchange Act of 1934, as Amended, and That This Agreement Shall Be Included as an Exhibit to This Schedule 13g. Each of the Undersigned Agrees to Be Responsible for the Timely Filing of the Schedule 13g, and for the Completeness and Accuracy of the Information Concerning Itself Contained Therein. This Agreement May Be Executed in Any Number of Counterparts, All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Have Executed This Agreement as of the 1st Day of November 1, 2001. Orbimed Advisers Inc. By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: President Orbimed Advisors LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: Managing Member

from SC 13G 1 page Joint Filing Agreement Exhibit 1.1 Joint Filing Agreement the Undersigned Hereby Agree That the Statement on This Schedule 13g, Dated November 1, 2001, (The "Schedule 13g"), With Respect to the Common Stock, Par Value Nis 0.05 Per Share, of Triangle Pharmaceuticals Inc. Is Filed on Behalf of Each of US Pursuant to and in Accordance With the Provisions of Rule 13d-1(k) Under the Securities and Exchange Act of 1934, as Amended, and That This Agreement Shall Be Included as an Exhibit to This Schedule 13g. Each of the Undersigned Agrees to Be Responsible for the Timely Filing of the Schedule 13g, and for the Completeness and Accuracy of the Information Concerning Itself Contained Therein. This Agreement May Be Executed in Any Number of Counterparts, All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Have Executed This Agreement as of the 1st Day of November 1, 2001. Orbimed Advisers Inc. By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: President Orbimed Advisors LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: Managing Member

from SC 13G 1 page Joint Filing Agreement Exhibit 1.1 Joint Filing Agreement the Undersigned Hereby Agree That the Statement on This Schedule 13g, Dated November 1, 2001, (The "Schedule 13g"), With Respect to the Common Stock, Par Value Nis 0.05 Per Share, of Triangle Pharmaceuticals Inc. Is Filed on Behalf of Each of US Pursuant to and in Accordance With the Provisions of Rule 13d-1(k) Under the Securities and Exchange Act of 1934, as Amended, and That This Agreement Shall Be Included as an Exhibit to This Schedule 13g. Each of the Undersigned Agrees to Be Responsible for the Timely Filing of the Schedule 13g, and for the Completeness and Accuracy of the Information Concerning Itself Contained Therein. This Agreement May Be Executed in Any Number of Counterparts, All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Have Executed This Agreement as of the 1st Day of November 1, 2001. Orbimed Advisers Inc. By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: President Orbimed Advisors LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: Managing Member

from SC 13D 1 page <page> Exhibit 1 Joint Filing Agreement the Undersigned Hereby Agree That the Statement on Schedule 13d Filed by the Undersigned With Respect to the Common Stock of Triangle Pharmaceuticals, Inc. Is, and Any Amendment Thereto Signed by Each of the Undersigned Shall Be, Filed on Behalf of Each Undersigned Pursuant to and in Accordance With the Provisions of Rule 13d-1(k) Under the Securities Exchange Act of 1934, as Amended. Dated: September 4, 2001 Warburg Pincus Private Equity VIII, L.P. By: Warburg, Pincus & Co., General Partner By: /S/ Scott Arenare Name: Scott Arenare Title: Attorney in Fact Dated: September 4, 2001 Warburg, Pincus & Co. By: /S/ Scott Arenare Name: Scott Arenare Title: Attorney in Fact Dated: September 4, 2001 Warburg Pincus LLC By: /S/ Scott Arenare Name: Scott Arenare Title: Vice President

from 8-K ~50 pages Common Stock Underwriting Agreement

from 8-A12G/A ~5 pages Underwriting agreement

from S-3 ~20 pages Underwriting Agreement

from SC 13G/A 1 page <page> Exhibit 1 Agreement Pursuant to Rule 13d-1(f) Promulgated Pursuant to the Securities Exchange Act of 1934, as Amended, the Undersigned Agree That the Attached Schedule 13g Is Being Filed on Behalf of Each of the Undersigned. February 13, 1998 Venrock Associates By: /S/ Ted H. McCourtney Ted H. McCourtney General Partner February 13, 1998 Venrock Associates II, L.P. By: /S/ Ted H. McCourtney Ted H. McCourtney General Partner February 13, 1998 General Partners /S/Mark W. Bailey Mark W. Bailey /S/ Anthony B. Evnin Anthony B. Evnin /S/ David R. Hathaway David R. Hathaway /S/ Patrick F. Latterell Patrick F. Latterell /S/ Ted H. McCourtney Ted H. McCourtney /S/ Ray A. Rothrock Ray A. Rothrock /S/ Kimberley A. Rummelsburg Kimberley A. Rummelsburg /S/ Anthony Sun Anthony Sun

from S-1/A ~10 pages International Underwriting Agreement

from S-1/A ~20 pages Form of U.S. Underwriting Agreement